PharMerica Corporation (NYSE: PMC), a national provider of institutional pharmacy, specialty infusion and hospital pharmacy management services, today announced that the Company has appointed David W. Froesel, Jr. as interim Chief Financial Officer, effective immediately. Mr. Froesel succeeds Michael J. Culotta, who by mutual agreement with the Company, is stepping down to pursue other interests.A veteran of the health care industry, Mr. Froesel served for 14 years as Chief Financial Officer of Omnicare, Inc. At PharMerica, he will be responsible for the management of all finance related functions. The Company has engaged an executive search firm to assist it with its search for a permanent CFO.<br /><br />Gregory S. Weishar, PharMerica Corporation’s Chief Executive Officer, said, “Dave is a world-class leader with a proven track record in our industry. His thorough understanding of our business, combined with his financial expertise and deep relationships with the investment community, make him ideally suited to oversee PharMerica’s financial functions.” “I am excited to join PharMerica,” said David Froesel. “PharMerica is highly regarded for its customer-centric technologies and superior pharmacy services. The Company is well positioned to realize additional opportunities in the market and continue creating shareholder value. I look forward to being part of the PharMerica team on an interim basis and contributing to the Company’s continued success.”<br /><br />Mr. Weishar added, “On behalf of the Board and management team of PharMerica, I want to thank Mike for his years of service to the Company. He played an important role in taking the Company public and developing a strong financial organization. We wish him the best in his future endeavors.”<br /><br />PharMerica noted that Mr. Culotta’s decision to step down was not related to any disputes with the Company or any issues regarding the integrity of the Company’s financial statements or accounting policies and practices.